Compare CSX Corporation (CSX) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Recursion Pharmaceuticals Inc — how do they compare? CSX Corporation trades at $50.06 (market cap $92.55B), while Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B). The key difference: CSX Corporation is far larger — about 51.1× Recursion Pharmaceuticals Inc's market cap, and CSX Corporation pays a 1.12% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CSX | RXRX | |
|---|---|---|
Market Cap | $92.55B | $1.81B |
Sector | Industrials | Health |
52-Week High | $53.21 | $6.79 |
52-Week Low | $32.05 | $2.84 |
Enterprise Value | $110.52B | $1.33B |
Dividend Yield | 1.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
